ANAB vs J · rev $91.3M vs P/E 36, $14.40B cap
AnaptysBio Inc (ANAB) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ANAB revenue for 2024-12-31 was $91.3M. Net income was -$145.2M. Revenue was up 432.0% from 2023-12-31 to 2024-12-31. ANAB currently screens at market cap $1.62B.
J does not have a complete income-statement cache yet.
ANAB currently screens at market cap $1.62B. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ANAB and J stock pages for the full models.
Not investment advice.